In a discovery that reframes how scientists understand one of the most common causes of nephrotic syndrome, researchers have shown that podocytes—the delicate filtration cells of the kidney—are not ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced the appointment of Gabriela Alperovich, MD, PhD, ...
Researchers at the Francis Crick Institute, King's College London and Complutense University of Madrid have shown that γδ T ...
Mivocabtagene autoleucel (miv-cel), an autologous CD19 chimeric antigen receptor (CAR)-T cell therapy, showed benefits ...
Hema Renew Blood Optimizer has announced the introduction of HemaRenew, a multi-ingredient dietary supplement developed for ...
During pregnancy, the human embryo is initially supplied with nutrients through the yolk sac; later, the placenta takes over ...
Researchers analyzed dietary data from 204,938 UK Biobank participants and identified blood protein and metabolite profiles ...
Aging progressively affects the functioning of our body and, among other things, deteriorates the ability of the ...
Adicet Bio, Inc. announced safety and efficacy data from the Phase 1 study evaluating prulacabtagene leucel (prula-cel) as a potential treatment for patients with systemic lupus erythematosus (SLE) ...
A preclinical study explores collagen-targeted IL-12 plus doxorubicin in osteosarcoma, enhancing local immune activation ...
Can the immune system detect cancer before it becomes clinically visible? Explore TCR repertoires, autoantibodies, AI, ctDNA, and immune fingerprints for early cancer detection.
One of the most stubborn obstacles in cancer immunotherapy is not the tumor cell itself but the cellular entourage that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results